0 Evaluaciones
ID

32733

Descripción

Study ID: 109059 Clinical Study ID: OTB109059 Study Title: TXA107979:A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men with Premature Ejaculation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01021553 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: epelsiban Trade Name: Study Indication: Premature Ejaculation

Palabras clave

Versiones (1)
  1. 13/11/18 13/11/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

13 de noviembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Delay in IELT, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK557296 in Men with Premature Ejaculation, 109059

    Inglés

    IP Compliance - Dispensed

    1 formularios  
    IP Compliance - Dispensed
    Descripción

    IP Compliance - Dispensed

    Alias
    UMLS CUI-1
    C0304229
    UMLS CUI-2
    C1321605
    UMLS CUI-3
    C1880359
    Date Dispensed
    Descripción

    Experimental Drug, Dispense, Date in time

    Tipo de datos

    date

    Alias
    UMLS CUI [1,1]
    C0304229
    UMLS CUI [1,2]
    C1880359
    UMLS CUI [1,3]
    C0011008
    First Blister Card Number
    Descripción

    Experimental Drug, Blister Pack, First, Number

    Tipo de datos

    integer

    Alias
    UMLS CUI [1,1]
    C0304229
    UMLS CUI [1,2]
    C1706080
    UMLS CUI [1,3]
    C0205435
    UMLS CUI [1,4]
    C0237753
    Total Number of Tablets from first blister card dispensed
    Descripción

    Experimental Drug, Dispense, Blister Pack, First, Count of entities

    Tipo de datos

    integer

    Alias
    UMLS CUI [1,1]
    C0304229
    UMLS CUI [1,2]
    C1880359
    UMLS CUI [1,3]
    C1706080
    UMLS CUI [1,4]
    C0205435
    UMLS CUI [1,5]
    C0449788
    Second Blister Card Number
    Descripción

    Experimental Drug, Blister Pack, Second, Number

    Tipo de datos

    integer

    Alias
    UMLS CUI [1,1]
    C0304229
    UMLS CUI [1,2]
    C1706080
    UMLS CUI [1,3]
    C0205436
    UMLS CUI [1,4]
    C0237753
    Total Number of Tablets from second blister card dispensed
    Descripción

    Experimental Drug, Dispense, Blister Pack, Second, Count of entities

    Tipo de datos

    integer

    Alias
    UMLS CUI [1,1]
    C0304229
    UMLS CUI [1,2]
    C1880359
    UMLS CUI [1,3]
    C1706080
    UMLS CUI [1,4]
    C0205436
    UMLS CUI [1,5]
    C0449788
    Volver a la parte superior de la página

    Similar models

    IP Compliance - Dispensed

    1 formularios
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    IP Compliance - Dispensed
    C0304229 (UMLS CUI-1)
    C1321605 (UMLS CUI-2)
    C1880359 (UMLS CUI-3)
    Experimental Drug, Dispense, Date in time
    Item
    Date Dispensed
    date
    C0304229 (UMLS CUI [1,1])
    C1880359 (UMLS CUI [1,2])
    C0011008 (UMLS CUI [1,3])
    Experimental Drug, Blister Pack, First, Number
    Item
    First Blister Card Number
    integer
    C0304229 (UMLS CUI [1,1])
    C1706080 (UMLS CUI [1,2])
    C0205435 (UMLS CUI [1,3])
    C0237753 (UMLS CUI [1,4])
    Experimental Drug, Dispense, Blister Pack, First, Count of entities
    Item
    Total Number of Tablets from first blister card dispensed
    integer
    C0304229 (UMLS CUI [1,1])
    C1880359 (UMLS CUI [1,2])
    C1706080 (UMLS CUI [1,3])
    C0205435 (UMLS CUI [1,4])
    C0449788 (UMLS CUI [1,5])
    Experimental Drug, Blister Pack, Second, Number
    Item
    Second Blister Card Number
    integer
    C0304229 (UMLS CUI [1,1])
    C1706080 (UMLS CUI [1,2])
    C0205436 (UMLS CUI [1,3])
    C0237753 (UMLS CUI [1,4])
    Experimental Drug, Dispense, Blister Pack, Second, Count of entities
    Item
    Total Number of Tablets from second blister card dispensed
    integer
    C0304229 (UMLS CUI [1,1])
    C1880359 (UMLS CUI [1,2])
    C1706080 (UMLS CUI [1,3])
    C0205436 (UMLS CUI [1,4])
    C0449788 (UMLS CUI [1,5])
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial